Source record
Include final version, tables, figures, disclosures, and references.
Technical and health records / document guide
English to Slovak clinical study summary translation
A study summary combines objectives, design, results, and limitations. Explain whether the Slovak reader is a patient, researcher, or regulator.
Prepared by English To Slovak, LLC · Published 26 September 2026 · Updated 8 October 2026
Explore translation services No document upload needed to start
Start here
Request a translation quote
Document: Clinical Study Summary. Include the approximate length, recipient, and deadline if you know them. We’ll review your request and may contact you by email about next steps.
What to know
Match the summary to its audience and approved study record
A scientific abstract, protocol synopsis, and results summary for lay readers have different purposes and levels of detail.
Reader and purpose
Endpoints, adverse events, statistical qualifiers, and population descriptions need consistent language.
Quote details
Ask whether a lay summary or technical abstract is required.
Document guide
What to check before ordering
These notes help you describe your request. The receiving organization’s current instructions should guide the final requirements.
Name the document and intended reader
Identify whether the English source is a protocol synopsis, published abstract, scientific results summary, layperson summary, or internal study brief. State the sponsor or author, study identifier, approved version, intended Slovak reader, and whether the request is a faithful translation or a separately reviewed plain-language adaptation. Do not use a protocol description as though it were final results.
Identify a dossier module by its actual title
EMA distinguishes a clinical overview, a clinical summary, and reports on individual studies. In the Common Technical Document, these correspond to modules 2.5, 2.7, and 5.3: a clinical summary can cover the submitted clinical information, rather than only one trial. If your English file belongs to that package, give the module and document title, approved version, included studies, appendices, and intended reader. Ask the sponsor or regulatory owner which text needs Slovak translation and why. Do not scope an entire dossier module as a short abstract or assume that every regulatory submission requires a Slovak version.
Keep study boundaries with the results
Include study population, eligibility, intervention and comparator, endpoints, dates, sample size, main findings, adverse events, limitations, tables, figures, and disclosures that appear in the approved source. Preserve the difference between an observed association and a proven effect, and between a planned and measured endpoint. A missing subgroup or statistical qualification can change the apparent claim. Refer source discrepancies to the study owner.
Check any regulated lay-summary route
The European Commission’s clinical-trial guidance distinguishes the technical results summary from the summary for laypersons under the EU Clinical Trials Regulation. Those requirements apply to the relevant regulated trials; they should not be assumed for every study brief. If the text is for that route, the sponsor or regulatory owner must confirm the required content, language, and submission process. Translation alone is not scientific or regulatory approval.
Quote scientific and layout work clearly
Give approximate words, tables and figures, source and target audience, document stage, terminology list, reviewer, output format, and deadline. State whether adaptation and final scientific review are in scope. Avoid entering patient data, unpublished findings, or confidential trial identifiers in the public quote form; share sensitive files through an authorized process after scoping.
How it works
How to request a quote
Tell us what the document is, who needs the Slovak translation, and when you need it. The first form does not require a file.
Describe the document
Choose the type and tell us where the translation will be used.
Add your requirements
Include the approximate length, deadline, and any instructions from the recipient.
Review and next steps
We review the request and may contact you by email if more detail is needed.
Frequently asked
Common questions
Answers to common questions before you request a quote.
Can a technical summary simply be made shorter for patients?
A patient-facing adaptation needs its own scope and scientific review so key results and limitations remain accurate.
Does translation establish that a treatment is effective?
No. The approved study record and qualified reviewers determine what conclusions the evidence supports.
Is a CTD clinical summary the same as a single-study abstract?
No. EMA describes the clinical summary as a dossier component covering submitted clinical information. Identify the actual module, document set, and reader before requesting a translation quote.
Ready when you are
Have an English document to translate?
Start with a few details. No file upload is needed for the first step.